Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Mayr-Melnhof Group in connection with its acquisition of Eson Pac
Mandate

Vinge has advised Mayr-Melnhof Group in connection with its acquisition of Eson Pac

April 11, 2022 Banking and Finance Commercial Agreements Intellectual Property M&A Corporate Crime & Compliance IT, Telecommunications and Outsourcing Real Estate and Construction Environmental Law

Eson Pac are packaging specialists providing solutions for the pharma packaging supply chain. Mayr-Melnhof Group (“MM”) has acquired 100% of the shares in Eson Pac from the majority shareholder Nalka Invest AB as well as the founding family and management minority shareholders. MM is Europe’s leading producer of cartonboard and folding cartons as well as kraft papers and uncoated fine papers.

Vinge’s team consisted of Matthias Pannier, Ulrich Ziche, Måns Håkanson and Elias Bohlin (M&A), Felix Möller and Ellen Flygt (Banking and Finance), Elin Broman and Emil Lindwall (Employment), Michael Montner (IP), Mario Saad (Commercial Agreements), Mika Jordan (IT), Tove Tullberg (Compliance), Frida Ställborn (Real Property), Johan Cederblad and Lina Österberg (Environmental law).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026